A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis.

Autor: Iaffaldano, Pietro1 (AUTHOR), Lucisano, Giuseppe2 (AUTHOR), Guerra, Tommaso1 (AUTHOR), Paolicelli, Damiano1 (AUTHOR), Portaccio, Emilio3 (AUTHOR), Inglese, Matilde4,5 (AUTHOR), Foschi, Matteo6 (AUTHOR), Patti, Francesco7 (AUTHOR), Granella, Franco8 (AUTHOR), Romano, Silvia9 (AUTHOR), Cavalla, Paola10 (AUTHOR), De Luca, Giovanna11 (AUTHOR), Gallo, Paolo12 (AUTHOR), Bellantonio, Paolo13 (AUTHOR), Gallo, Antonio14 (AUTHOR), Montepietra, Sara15 (AUTHOR), Di Sapio, Alessia16 (AUTHOR), Vianello, Marika17 (AUTHOR), Quatrale, Rocco18 (AUTHOR), Spitaleri, Daniele19 (AUTHOR)
Zdroj: Annals of Clinical & Translational Neurology. Aug2024, Vol. 11 Issue 8, p2008-2015. 8p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje